Document is current
Any future updates will be listed below
-
Authors
Liu, Jing
Kario, Kazuomi
Ding, Xiaoqiang
Li, Zixiao
Gao, Tianli
Li, Yan
Zhang, Yuqing
Chen, Wei
Chia, Yook-Chin
Fan, Yuhua
Hoshide, Satoshi
Mao, Huijuan
Shin, Jinho
Sukonthasarn, Apichard
Teo, Boon Wee
Turana, Yuda
Yao, Li
Zhang, Hong
Wang, Ji-Guang
- License Information
-
More Information
Article History
Received: 17 December 2025
Revised: 21 March 2026
Accepted: 31 March 2026
First Online: 12 May 2026
Compliance with ethical standards
:
: BWT reports lecture fees, advisory board fees, or is a clinical trial investigator from Astra-Zeneca, Bayer, Baxter, Boehringer-Ingelheim, DKSH, Novartis, Otsuka, Radiant Pharmaceuticals, Roche, Takeda, and Vera Therapeutics. CYC has received speaker honorarium from Medtronic, Omron, Viatris and an educational grant from Medtronic on behalf of MyWASSH and from Viatris on behalf of the HOPE-Asia Network. HZ declares no conflicts of interest relevant to this work. JS reports honoraria from Skylabs, Menarini, Celltrion, and Novartis. J-GW reports having received lecture and consulting fees from AstraZeneca, Medtronic, Novartis, and Viatris. KK reports funded/joint research fees and lecture fees from Omron Healthcare, A&D, and Fukuda Denshi. LY reports no known competing financial interests or personal relationships that could have appeared to influence the work reported in this consensus. YL reports having received research grants from A&D, Bayer, Omron, Salubris, and Shyndec and lecture fees from A&D, Servier, Salubris, and Viatris.
